BOULDING MARK ELLIOTT (Exec. VP and CLO) sold 2.8% of their position (3.02K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $209.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/23/2026ACC: 0001578852-26-000010
Officer· Exec. VP and CLO
Since Jan 2019
-3.02K
Net shares
Net seller
$209.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
3.02K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−588.00
Price / share
$68.54
Trade value
$40.30K
% of position
0.5%
2/19/2026
108.23K→107.64K
Common Stock
Direct
Shares
−1.63K
Price / share
$69.82
Trade value
$113.74K
% of position
1.5%
2/19/2026
107.64K→106.01K
Common Stock
Direct
Shares
−212.00
Price / share
$68.54
Trade value
$14.53K
% of position
0.2%
2/19/2026
106.01K→105.80K
Common Stock
Direct
Shares
−590.00
Price / share
$69.82
Trade value
$41.19K
% of position
0.6%
2/19/2026
105.80K→105.21K
Total
Net shares
−3.02K
Net value
-$209.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | S · Sale | −588.00 | $68.54 | $40.30K | 0.5% | 108.23K | 107.64K |
| Common Stock Direct | 2/19/2026 | S · Sale | −1.63K | $69.82 | $113.74K | 1.5% | 107.64K | 106.01K |
| Common Stock Direct | 2/19/2026 | S · Sale | −212.00 | $68.54 | $14.53K | 0.2% | 106.01K | 105.80K |
| Common Stock Direct | 2/19/2026 | S · Sale | −590.00 | $69.82 | $41.19K | 0.6% | 105.80K | 105.21K |
| Total | −3.02K | -$209.76K | ||||||
Derivative Transactions0
No derivative transactions reported